Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4690490 | 0.93 | CCR5 (0.64) | CCR5KCNH2 | |
| SCHEMBL4695267 | 0.92 | CCR5 (0.65) | CCR5KCNH2 | |
| SCHEMBL4694591 | 0.90 | CCR5 (0.65) | CCR5KCNH2 | |
| SCHEMBL4691650 | 0.89 | CCR5 (0.60) | CCR5KCNH2 | |
| Trifluoroacetic Acid SCHEMBL5267130 | 0.88 | CCR5 (0.61) | CCR5KCNH2 | |
| SCHEMBL13326699 | 0.88 | CCR5 (0.50) | CCR5KCNH2 | |
| SCHEMBL3283072 | 0.88 | CCR5 (0.50) | CCR5KCNH2 | |
| SCHEMBL5428452 | 0.87 | KCNH2 (0.62) | CCR5KCNH2 | |
| SCHEMBL13326681 | 0.87 | KCNH2 (0.62) | CCR5KCNH2 | |
| SCHEMBL4692380 | 0.86 | CCR5 (0.73) | CCR5KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1761542-B1 | OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS | HOFFMANN LA ROCHE (CH) | 2008-01-02 | — | — | EP | claimed |
| EP-1761542-A2 | OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS | F.HOFFMANN-LA ROCHE AG (CH) | 2007-03-14 | — | — | EP | claimed |
| WO-2005121145-A2 | OCTAHYDRO-PYRROLO[3,4-C] DERIVATIVES AND THEIR USE AS ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2005-12-22 | — | — | WO | claimed |
| EP-1761542-B1 | OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS | HOFFMANN LA ROCHE (CH) | 2008-01-02 | — | — | EP | disclosed |